company? Let’s change
that.
Don't see your company?
Create a company profileAndelyn Biosciences is a biopharmaceutical CDMO Pioneering Solutions That Turn Hope into Reality™. Capabilities span viral vector and vaccine process and analytical development, small to large scale adherent and suspension based GMP drug substance manufacturing up to 2000L, and finished drug product manufacturing services located in Columbus, OH USA. Having 20+ years of experience with viral vector and vaccine manufacturing, Andelyn offers its clients direct access to globally recognized thought leaders with troubleshooting / characterization expertise and GMP material produced for over 75+ worldwide clinical trials. In addition to producing over 400+ cGMP clinical batches and 2000+ research-grade productions, Andelyn currently provides research and tox grade plasmids with an additional offering of GMP plasmid manufacturing (early 2022), advanced quality systems, full regulatory support, semi-automated to automated fill stations, and supply chain vertical integration. Its state-of-the-art 185,000 sq ft clinical and commercial manufacturing facility comprises 14+ upstream production suites for customization of new programs and tech transferred programs. Andelyn offers clinical through commercial-scale capabilities that will help accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients
Rewriting the next 100 years of farming
CiiTA is provides expertise and actionable intelligence to pharmaceutical and biotechnology manufacturers.
Revolve Biotechnologies is a biotechnology platform.
Lynx Biosciences, Inc. is a cytomics company focused on transforming the development of blood cancer therapies.
Founded in 1998 to support HIV vaccine research, ProSci has utilized its infectious disease expertise to develop exceptional, high-quality antibodies, recombinant proteins, and other reagents for a vast number of research areas. As one of the first companies to market COVID-19 products, ProSci holds a broad catalog of SARS-CoV-2 reagents and is continuously expanding our portfolio. ProSci also specializes in custom monoclonal, polyclonal, and single domain antibody development. Using several techniques including hybridoma technology, plasma cell cloning, and phage display, we can create antibodies that target the most difficult antigens that you can find. Call us for a free consultation to develop the perfect antibody for you.
Vow is a cultured meat company, founded and operated in Sydney, Australia. We’re a multidisciplinary team of scientists, technologists and designers, all working together to make sustainable food both irresistible and available to billions of people.
NextSource Biotechnology is a biotechnology and pharmaceutical company located in Miami.
Ascent is a bio-tech start-up incorporated in 2012. It is a spin-off from The Pennsylvania State University and Duke University. Ascent focuses on development and commercialization of acoustofluidic (i.e., the fusion of acoustics and microfluidics) chips and instruments for research, diagnostic, and therapeutic applications. It has a strong IP portfolio on acoustofluidic technologies (exclusive license for 4 issued US patents and >10 issued/pending patents in China, Japan, Europe, and North America).
Texcell-North America, Inc. is a global contract research organization based in the Maryland/Virginia biotech corridor specializing in custom cell culture, virus propagation, virus concentration, viral clearance services, and viral safety testing in support of biopharmaceutical applications submitted to the FDA and other regulatory authorities. Since 2002, our team has cultivated an ever-increasing range of experience performing viral clearance studies for a wide variety of purification steps including chromatography, filtration, and inactivation methods, as well as evaluations of column age and sanitization, or cleaning efficacy. We offer our clients a personalized and tailored approach to study design with the advantage of an extensive historical viral clearance database of over 9,000 studies performed by our global organization. Through partnerships with other Texcell facilities around the world, we have expanded our services portfolio to include cGMP cell bank production, cell bank characterization and GMP compliant animal studies. We are proud to support research that continues to improve global quality of life. Let us be an extension of your laboratory. To find out more about our viral safety, viral clearance, cell culture and viral propagation capabilities, visit our website or contact us at the link below: http://www.texcell.com/contact-us/
NICU Feeding Management, Lactation Analytics & Patient Engagement
Agenus is an immuno-oncology company driven by innovation and speed. Our goal is to treat cancers with novel combinations utilizing our unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines and adjuvants. In addition to a broad portfolio, we have an accomplished team of scientists, novel technology platforms and fully-integrated end-to-end capabilities from discovery to GMP manufacturing. With our remarkable combination of science and people, we believe that we are uniquely positioned to bring curative treatments to cancer patients. For more information, please visit www.agenusbio.com; information that may be important to investors will be routinely posted on our website. Follow @Agenus_Bio on Twitter to stay up to date! https://twitter.com/Agenus_Bio
Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies. Halozyme advises and supports its biopharmaceutical partners in key aspects of new drug development with the goal of improving patients' lives while helping its partners achieve global commercial success. As the innovators of the ENHANZE® technology, which can reduce hours-long treatments to a matter of minutes, Halozyme's commercially-validated solution has positively impacted more than 400,000 patient lives via five commercialized products across more than 100 global markets. Halozyme and its world-class partners are currently advancing multiple therapeutic programs intended to deliver innovative therapies, with the potential to improve the lives of patients around the globe. Halozyme's proprietary enzyme rHuPH20 forms the basis of the ENHANZE® technology and is used to facilitate the delivery of injected drugs and fluids, potentially reducing the treatment burden of other drugs to patients. Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Baxalta, Pfizer, Janssen, AbbVie, Lilly, Bristol-Myers Squibb, Alexion and argenx. Halozyme derives revenues from these collaborations in the form of milestones and royalties as the company's partners make progress developing and commercializing their products being developed with ENHANZE®. We are a diverse team, who are committed to bringing therapies and results to patients. It's not enough to be qualified and experienced at what you do, we are looking for people who believe in our mission and match our values. We are building a company where people can pursue their career goals in a supportive and collaborative team environment. Visit www.halozyme.com/careers for more details. We are Halozyme.
Dragonfly Therapeutics is a clinical-stage biotech developing novel first-in-class therapeutics targeted at natural killer cells and other cells of the innate immune system. These therapies are designed to counterbalance immune suppressive factors present in the tumor microenvironment and mobilize anti-cancer immune responses. Our molecules are expected to be potent as single agents as well as in treatment combinations with existing cancer immunotherapies. Our scientific founders are major figures in cancer biology and immunology and have launched Dragonfly to harness the power of the immune system to provide breakthrough cancer treatments for patients. For more information, email [email protected].
Bioethic Consulting—Powered by Mankind Empowered, Engaged Resources for Today’s Life Science Industry Quality Assurance - Time Management with Integrity Top-tier professionals lead your quality assurance team through project inception to final completion. Successful timeline management ensures objectives are met within budget considerations. Industry experts provide systematic monitoring and evaluation of adherence to core principles unique to life sciences. Remediation Services - Effective Remediation Solutions We work to uncover and identify primary causes of ongoing compliance issues within your system. By implementing proven strategic solutions that ensure 100% compliance throughout the life science industry, we continue to protect your greatest asset: your reputation. Critical to successful operations and relationships, your good name precedes you and your project. Clinical Operations - Professional Synergy, Integrated Workforce We bring leading edge industry professionals to the table to carefully create or augment your top-notch clinical operations team. Engaged, energetic, progressive talent work together with existing personnel to deliver timely, cost-effective, flexible clinical support. Regulatory Affairs - Proven Success with Regulatory Compliance We know the time and energy it takes to prepare for an industry audit and the manpower needed to successfully respond to regulatory action. We work together with your organization to effectively manage regulatory submissions and provide ongoing support throughout the entire process. Our preemptive approach to regulatory management ensures compliance issues are identified and resolved before they further escalate. Engineering Targeted Support for Engineering Operations We believe in empowering key personnel that share the vision for your mission to implement timely, focused strategies that deliver measurable results.
AgroSpheres is transforming agriculture through reliable and affordable biobased solutions.
Hera Testing Laboratories develops preclinical drugs for vivo and vitro toxicology.
Jeevan Biosciences is committed to the development of cellular models for the investigation of neurologic diseases and drug testing.
Anubis Bio is an animal health company employing passive immunity to develop products for the treatment of infections in animals.
Akadeum Life Sciences, an emerging life science startup, is located in Ann Arbor, MI. Founded in 2014, Akadeum was established to create advanced isolation products and to fundamentally change the way that isolating chemical and biological targets is approached. At Akadeum, we strive to disrupt the status quo by delivering a technology that can isolate any sample, any volume, anywhere.